Knee Segment Held Largest Share of Cartilage Degeneration Market in 2019
According to the new market research study on “South & Central America Cartilage Degeneration Market to 2027 - Regional Analysis and Forecast - by Procedure Type, Application and End User” the market is expected to reach US$1,195.57 million by 2027 from US$959.32 million in 2019; it is estimated to grow at a CAGR of 2.9% from 2020 to 2027. The report provides trends prevailing in the South & Central America cartilage degeneration market and the factors driving the market growth along with those hindering it.
In 2019, the knee segment accounted for the highest share of the market. Growth of this segment is attributed to the increasing prevalence of knee injuries. Furthermore, increasing awareness of benefits provided by cartilage repair is also anticipated to drive the growth of knee segment.
The growth of the South & Central America cartilage degeneration market is mainly attributed to growing number of sports injuries, and increasing prevalence of obesity. However, high cost of cartilage repair therapies is expected to restrict the market growth during the forecast period.
B. Braun Melsungen AG; Smith & Nephew; Stryker Corporation, CartiHeal, Inc.; and Vericel Corporation are among the leading companies operating in the South & Central America cartilage degeneration market.
The Report Segments South & Central America Cartilage Degeneration Market as Follows:
South & Central America Cartilage Degeneration Market - By Procedure Type
South & Central America Cartilage Degeneration Market - By Application
South & Central America Cartilage Degeneration Market - By End User
South & Central America Cartilage Degeneration Market - By Country
Reasons to Buy
According to the new market research study on “South & Central America Cartilage Degeneration Market to 2027 - Regional Analysis and Forecast - by Procedure Type, Application and End User” the market is expected to reach US$1,195.57 million by 2027 from US$959.32 million in 2019; it is estimated to grow at a CAGR of 2.9% from 2020 to 2027. The report provides trends prevailing in the South & Central America cartilage degeneration market and the factors driving the market growth along with those hindering it.
In 2019, the knee segment accounted for the highest share of the market. Growth of this segment is attributed to the increasing prevalence of knee injuries. Furthermore, increasing awareness of benefits provided by cartilage repair is also anticipated to drive the growth of knee segment.
The growth of the South & Central America cartilage degeneration market is mainly attributed to growing number of sports injuries, and increasing prevalence of obesity. However, high cost of cartilage repair therapies is expected to restrict the market growth during the forecast period.
B. Braun Melsungen AG; Smith & Nephew; Stryker Corporation, CartiHeal, Inc.; and Vericel Corporation are among the leading companies operating in the South & Central America cartilage degeneration market.
The Report Segments South & Central America Cartilage Degeneration Market as Follows:
South & Central America Cartilage Degeneration Market - By Procedure Type
- Joint Replacement
- Chondroplasty
- Cell-based Cartilage Resurfacing
- Osteochondral Transplant
- Meniscus Transplants
- Others
South & Central America Cartilage Degeneration Market - By Application
- Knee
- Hips
- Others
South & Central America Cartilage Degeneration Market - By End User
- Hospitals and Specialty Clinics
- Ambulatory Surgical Centers
- Academic and Research Institutes
South & Central America Cartilage Degeneration Market - By Country
- South & Central America
- Brazil
- Argentina
- Rest of South & Central America
Reasons to Buy
- It provides an understanding of the South & Central America, cartilage degeneration market landscape and identifies cartilage degeneration market segments that are most likely to guarantee a strong return.
- Stay ahead of the race by comprehending the ever-changing competitive landscape for the South & Central America cartilage degeneration market.
- Efficiently plan merger and acquisition, and partnership deals in the cartilage degeneration market by identifying market segments with the most promising probable sales
- It facilitates knowledgeable business decision-making through perceptive and comprehensive analysis of cartilage degeneration market performance of various segments pertaining to the South & Central America cartilage degeneration market.It provides cartilage degeneration market revenue forecast of the market based on various segments for the period from 2019 to 2027.
Table of Contents
1. Introduction
3. Research Methodology
4. South & Central America Cartilage Degeneration Market - Market Landscape
5. South & Central America Cartilage Degeneration Market - Key Market Dynamics
6. Cartilage Degeneration Market - South & Central America Analysis
7. South & Central America Cartilage Degeneration Market Analysis and Forecasts To 2027 - By Procedure Type
8. South & Central America Cartilage Degeneration Market Analysis and Forecasts To 2027 - By Application
9. South & Central America Cartilage Degeneration Market Analysis - By End-User
10. Cartilage Degeneration Market Revenue and Forecasts To 2027 - Geographical Analysis
11. Impact of COVID-19 Pandemic on South & Central America Cartilage Degeneration Market
12. Company Profiles
13. Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- B. Braun Melsungen AG
- Smith & Nephew
- Stryker Corporation
- CartiHeal, Inc
- Vericel Corporation